Teva- Pharmaceutical Industries Ltd. ADR’s recently made public that its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 million on May 16 ’24. In the deal valued at $16.65 per share,12,635 shares were sold. As a result of this transaction, Weiss Amir now holds 5,179 shares worth roughly $86126.76999999999.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Weiss Amir sold 15,500 shares, generating $260,417 in total proceeds. Upon selling the shares at $16.80, the Chief Accounting Officer now owns 17,814 shares.
Before that, Conway Vikki L sold 15,219 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $254,807 were divested by the See “Remarks” at a price of $16.74 per share. As a result of the transaction, Conway Vikki L now holds 0 shares, worth roughly $0.0.
JP Morgan upgraded its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Neutral from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who increased its forecast for the stock in mid February from “a Neutral” to “an Overweight”. Jefferies also remained covering TEVA and has increased its forecast on January 23, 2024 with a “Buy” recommendation from previously “Hold” rating. Piper Sandler revised its rating on January 03, 2024. It rated TEVA as “a Neutral” which previously was an “an Underweight”.
Price Performance Review of TEVA
On Tuesday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -2.06% to $16.63. Over the last five days, the stock has lost -0.78%. Teva- Pharmaceutical Industries Ltd. ADR shares have risen nearly 59.29% since the year began. Nevertheless, the stocks have risen 130.01% over the past one year. While a 52-week high of $17.39 was reached on 06/03/24, a 52-week low of $7.14 was recorded on 01/02/24. SMA at 50 days reached $14.82, while 200 days put it at $11.70. A total of 7.41 million shares were traded, compared to the trading of 12.78 million shares in the previous session.
Levels Of Support And Resistance For TEVA Stock
The 24-hour chart illustrates a support level at 16.47, which if violated will result in even more drops to 16.30. On the upside, there is a resistance level at 16.94. A further resistance level may holdings at 17.25. The Relative Strength Index (RSI) on the 14-day chart is 60.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.71%. Stochastics %K at 64.73% indicates the stock is a holding.
The most recent change occurred on December 18, 2023 when HSBC Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.
